Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Phase 3 Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate to Severe Rheumatoid Arthritis.

Michael E Weinblatt,Asta Baranauskaite,Jaroslaw Niebrzydowski,Eva Dokoupilova,Agnieszka Zielinska,Janusz Jaworski,Artur Racewicz,Margarita Pileckyte,Krystyna Jedrychowicz-Rosiak,Soo Yeon Cheong,Jeehoon Ghil

ARTHRITIS & RHEUMATOLOGY（2018）

Cited 117|Views37
No score
Key words
adalimumab,biosimilar,immunogenicity,randomized trial,rheumatoid arthritis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined